Chemoinformaics analysis of DICYCLOHEXYLPHOSPHINE
| Molecular Weight | 198.29 | nRot | 2 |
| Heavy Atom Molecular Weight | 175.106 | nRig | 12 |
| Exact Molecular Weight | 198.154 | nRing | 2 |
| Solubility: LogS | -4.185 | nHRing | 0 |
| Solubility: LogP | 4.013 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 39.0062 |
| nHD | 0 | BPOL | 28.9538 |
| QED | 0.579 |
| Synth | 2.871 |
| Natural Product Likeliness | 0.095 |
| NR-PPAR-gamma | 0.081 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.999 |
| HIA | 0.007 |
| CACO-2 | -4.582 |
| MDCK | 0.0000208 |
| BBB | 0.325 |
| PPB | 0.963477 |
| VDSS | 2.099 |
| FU | 0.0155057 |
| CYP1A2-inh | 0.646 |
| CYP1A2-sub | 0.331 |
| CYP2c19-inh | 0.525 |
| CYP2c19-sub | 0.084 |
| CYP2c9-inh | 0.361 |
| CYP2c9-sub | 0.954 |
| CYP2d6-inh | 0.168 |
| CYP2d6-sub | 0.473 |
| CYP3a4-inh | 0.233 |
| CYP3a4-sub | 0.095 |
| CL | 3.855 |
| T12 | 0.117 |
| hERG | 0.037 |
| Ames | 0.083 |
| ROA | 0.057 |
| SkinSen | 0.927 |
| Carcinogencity | 0.296 |
| EI | 0.991 |
| Respiratory | 0.644 |
| NR-Aromatase | 0.064 |
| Antiviral | Yes |
| Prediction | 0.618048 |